These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7249549)
1. Differential toxicity and pharmacokinetics of sodium and Tris salts of 5-fluorouracil in the rat. Plumb JA; Gardner ML Clin Sci (Lond); 1981 Jun; 60(6):707-10. PubMed ID: 7249549 [TBL] [Abstract][Full Text] [Related]
2. Can elemental diets reduce the intestinal toxicity of 5-fluorouracil? Plumb JA; Gardner ML JPEN J Parenter Enteral Nutr; 1983; 7(4):351-7. PubMed ID: 6352981 [TBL] [Abstract][Full Text] [Related]
3. Locoregional application of 5-fluorouracil to the liver: alteration of pharmacokinetics and bone marrow toxicity in rats with thioacetamide-induced cirrhosis. Aguiar JL; Berger MR; Frank N Toxicol Lett; 1987 Apr; 36(2):181-8. PubMed ID: 3576649 [TBL] [Abstract][Full Text] [Related]
4. The effect of sulfhydryl compounds on 5-fluorouracil toxicity and distribution. Danysz A; Wierzba K; Pniewska A; Kłosiewicz S; Burba-Anczewska I Arch Immunol Ther Exp (Warsz); 1983; 31(3):373-9. PubMed ID: 6418114 [TBL] [Abstract][Full Text] [Related]
5. Non-linear pharmacokinetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracil. de Bruijn EA; Remeyer L; Tjaden UR; Erkelens C; de Brauw LM; van de Velde CJ Biochem Pharmacol; 1986 Aug; 35(15):2461-5. PubMed ID: 3741455 [No Abstract] [Full Text] [Related]
6. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850 [TBL] [Abstract][Full Text] [Related]
7. The effect of dietary protein depletion on hepatic 5-fluorouracil metabolism. Davis LE; Lenkinski RE; Shinkwin MA; Kressel HY; Daly JM Cancer; 1993 Dec; 72(12):3715-22. PubMed ID: 8252488 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy. Sadee W; Wong CG Clin Pharmacokinet; 1977; 2(6):437-50. PubMed ID: 589882 [TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients. Casale F; Canaparo R; Serpe L; Muntoni E; Pepa CD; Costa M; Mairone L; Zara GP; Fornari G; Eandi M Pharmacol Res; 2004 Aug; 50(2):173-9. PubMed ID: 15177306 [TBL] [Abstract][Full Text] [Related]
10. Diurnal variation in the intestinal toxicity of 5-fluorouracil in the rat. Gardner ML; Plumb JA Clin Sci (Lond); 1981 Dec; 61(6):717-22. PubMed ID: 7197602 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of 5-fluorouracil : impact of the measurement of the 5,6-dihydrofluorouracil. Aubert C; Cano JP; Rigault JP; Seitz JF; Carcassonne Y Bull Cancer; 1981; 68(4):343-5. PubMed ID: 7317660 [No Abstract] [Full Text] [Related]
13. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans. Benvenuto JA; Lu K; Hall SW; Benjamin RS; Loo TL Cancer Res; 1978 Nov; 38(11 Pt 1):3867-70. PubMed ID: 359130 [TBL] [Abstract][Full Text] [Related]
14. Absorption of 5-fluorouracil and related pyrimidines in rat small intestine. Bronk JR; Lister N; Lynch S Clin Sci (Lond); 1987 Jun; 72(6):705-16. PubMed ID: 3595076 [TBL] [Abstract][Full Text] [Related]
15. Effect of diets on 5-fluorouracil and cyclophosphamide toxicity. Chevreau N; Wang Y; Funk-Archuleta M Nutr Cancer; 1995; 23(2):205-20. PubMed ID: 7644388 [TBL] [Abstract][Full Text] [Related]